Memory CD8+ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection

Cell Host and Microbe

Volumn 13, Issue 5, 2013, Pages 546-557

  Remakus, Sanda ^a,b   Rubio, Daniel ^a,c   Lev, Avital ^a   Ma, Xueying ^a   Fang, Min ^a,d   Xu, Ren Huan ^a   Sigal, Luis J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CSIC   (Spain)

^d INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PERFORIN; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPREADING; CONTROLLED STUDY; CYTOLYSIS; ECTROMELIA VIRUS; EFFECTOR CELL; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNIZATION; INFECTION CONTROL; LIVER; MEMORY T LYMPHOCYTE; MOUSE; MOUSEPOX; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; SPLEEN;

EID: 84877853944     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.04.004     Document Type: Article

References (43)

1. V.P. Badovinac, K.A. Messingham, S.E. Hamilton, and J.T. Harty Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host J. Immunol. 170 2003 4933 4942
2. M.R. Betts, J.M. Brenchley, D.A. Price, S.C. De Rosa, D.C. Douek, M. Roederer, and R.A. Koup Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation J. Immunol. Methods 281 2003 65 78
3. M.R. Betts, M.C. Nason, S.M. West, S.C. De Rosa, S.A. Migueles, J. Abraham, M.M. Lederman, J.M. Benito, P.A. Goepfert, and M. Connors HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells Blood 107 2006 4781 4789
4. A. Billiau, and P. Matthys Interferon-gamma: a historical perspective Cytokine Growth Factor Rev. 20 2009 97 113
5. A. Cerwenka, and L.L. Lanier Natural killer cells, viruses and cancer Nat. Rev. Immunol. 1 2001 41 49
6. G. Chaudhri, V. Panchanathan, R.M. Buller, A.J. van den Eertwegh, E. Claassen, J. Zhou, R. de Chazal, J.D. Laman, and G. Karupiah Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox Proc. Natl. Acad. Sci. USA 101 2004 9057 9062
7. R.C. Davis, E.E. Schadt, D.J. Smith, E.W. Hsieh, A.C. Cervino, A. van Nas, M. Rosales, S. Doss, H. Meng, H. Allayee, and A.J. Lusis A genome-wide set of congenic mouse strains derived from DBA/2J on a C57BL/6J background Genomics 86 2005 259 270
8. M.L. Delano, and D.G. Brownstein Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype J. Virol. 69 1995 5875 5877
9. M. Fang, and L.J. Sigal Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus J. Immunol. 175 2005 6829 6836
10. M. Fang, and L.J. Sigal Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host J. Immunol. 177 2006 8027 8036
11. M. Fang, and L. Sigal Studying NK cell responses to ectromelia virus infections in mice Methods Mol. Biol. 612 2010 411 428
12. M. Fang, H. Cheng, Z. Dai, Z. Bu, and L.J. Sigal Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host Virology 345 2006 231 243
13. M. Fang, L.L. Lanier, and L.J. Sigal A role for NKG2D in NK cell-mediated resistance to poxvirus disease PLoS Pathog. 4 2008 e30
14. M. Fang, M.T. Orr, P. Spee, T. Egebjerg, L.L. Lanier, and L.J. Sigal CD94 is essential for NK cell-mediated resistance to a lethal viral disease Immunity 34 2011 579 589
15. M. Fang, N.A. Siciliano, A.R. Hersperger, F. Roscoe, A. Hu, X. Ma, A.R. Shamsedeen, L.C. Eisenlohr, and L.J. Sigal Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection Proc. Natl. Acad. Sci. USA 109 2012 9983 9988
16. F. Fenner Mousepox (ectromelia) A. Osterhaus, Virus Infections of Rodents and Lagomorphs 1994 Elsevier Science Amsterdam, New York 412
17. F. Fenner, D.A. Henderson, I. Arita, Z. Jezek, D. Ladnyi, and W.H. Organization Smallpox and Its Eradication 1988 World Health Organization Geneva, Switzerland
18. S.J. Flint, L.W. Enquist, V.R. Racaniello, and A.M. Skalka Principles of Virology Third Edition 2009 ASM Press Washington, DC
19. G. Guarda, M. Hons, S.F. Soriano, A.Y. Huang, R. Polley, A. Martín-Fontecha, J.V. Stein, R.N. Germain, A. Lanzavecchia, and F. Sallusto L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells Nat. Immunol. 8 2007 743 752
20. J.T. Harty, A.R. Tvinnereim, and D.W. White CD8+ T cell effector mechanisms in resistance to infection Annu. Rev. Immunol. 18 2000 275 308
21. S. Kannanganat, C. Ibegbu, L. Chennareddi, H.L. Robinson, and R.R. Amara Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells J. Virol. 81 2007 8468 8476
22. G. Karupiah, T.N. Fredrickson, K.L. Holmes, L.H. Khairallah, and R.M. Buller Importance of interferons in recovery from mousepox J. Virol. 67 1993 4214 4226
23. R.M. Kedl, W.A. Rees, D.A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, and P. Marrack T cells compete for access to antigen-bearing antigen-presenting cells J. Exp. Med. 192 2000 1105 1113
24. N.B. Marshall, and S.L. Swain Cytotoxic CD4 T cells in antiviral immunity J. Biomed. Biotechnol. 2011 2011 954602
25. M.D. Martin, T.C. Wirth, P. Lauer, J.T. Harty, and V.P. Badovinac The impact of pre-existing memory on differentiation of newly recruited naive CD8 T cells J. Immunol. 187 2011 2923 2931
26. M.D. Martin, S.A. Condotta, J.T. Harty, and V.P. Badovinac Population dynamics of naive and memory CD8 T cell responses after antigen stimulations in vivo J. Immunol. 188 2012 1255 1265
27. V. Panchanathan, G. Chaudhri, and G. Karupiah Interferon function is not required for recovery from a secondary poxvirus infection Proc. Natl. Acad. Sci. USA 102 2005 12921 12926
28. V. Panchanathan, G. Chaudhri, and G. Karupiah Antiviral protection following immunization correlates with humoral but not cell-mediated immunity Immunol. Cell Biol. 88 2010 461 467
29. A.K. Parker, S. Parker, W.M. Yokoyama, J.A. Corbett, and R.M. Buller Induction of natural killer cell responses by ectromelia virus controls infection J. Virol. 81 2007 4070 4079
30. M.L. Precopio, M.R. Betts, J. Parrino, D.A. Price, E. Gostick, D.R. Ambrozak, T.E. Asher, D.C. Douek, A. Harari, and G. Pantaleo Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses J. Exp. Med. 204 2007 1405 1416
31. S. Remakus, and L.J. Sigal Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response J. Virol. 85 2011 12578 12584
32. S. Remakus, D. Rubio, X. Ma, A. Sette, and L.J. Sigal Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease J. Virol. 86 2012 9748 9759
33. J.A. Trapani, and M.J. Smyth Functional significance of the perforin/granzyme cell death pathway Nat. Rev. Immunol. 2 2002 735 747
34. D.C. Tscharke, G. Karupiah, J. Zhou, T. Palmore, K.R. Irvine, S.M. Haeryfar, S. Williams, J. Sidney, A. Sette, J.R. Bennink, and J.W. Yewdell Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines J. Exp. Med. 201 2005 95 104
35. D.C. Tscharke, W.P. Woo, I.G. Sakala, J. Sidney, A. Sette, D.J. Moss, J.R. Bennink, G. Karupiah, and J.W. Yewdell Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice J. Virol. 80 2006 6318 6323
36. E. Tupin, Y. Kinjo, and M. Kronenberg The unique role of natural killer T cells in the response to microorganisms Nat. Rev. Microbiol. 5 2007 405 417
37. S.J. Turner, R. Cross, W. Xie, and P.C. Doherty Concurrent naive and memory CD8(+) T cell responses to an influenza A virus J. Immunol. 167 2001 2753 2758
38. R.E. Vance, A.M. Jamieson, D. Cado, and D.H. Raulet Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation Proc. Natl. Acad. Sci. USA 99 2002 868 873
39. G.D. Wallace, R.M. Buller, and H.C. Morse 3rd Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality J. Virol. 55 1985 890 891
40. R.M. Welsh, L.K. Selin, and E. Szomolanyi-Tsuda Immunological memory to viral infections Annu. Rev. Immunol. 22 2004 711 743
41. P. Wolint, M.R. Betts, R.A. Koup, and A. Oxenius Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells J. Exp. Med. 199 2004 925 936
42. R.H. Xu, M. Fang, A. Klein-Szanto, and L.J. Sigal Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection Proc. Natl. Acad. Sci. USA 104 2007 10992 10997
43. R.H. Xu, D. Rubio, F. Roscoe, T.E. Krouse, M.E. Truckenmiller, C.C. Norbury, P.N. Hudson, I.K. Damon, A. Alcamí, and L.J. Sigal Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver PLoS Pathog. 8 2012 e1002475.